- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daunorubicin,Ara-Cytarabine, azacitidine
Total 763 results
-
CelgeneCompletedLeukemia, Myeloid | Isocitrate DehydrogenaseUnited States, Canada, China, Czechia, France, Germany, Italy, United Kingdom, Australia, Austria, Brazil, Denmark, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, Belgium
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
St. Petersburg State Pavlov Medical UniversityTerminated
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, France, Spain, Australia, Czechia, United Kingdom, Italy, Germany, Greece, Poland, Russian Federation, Bulgaria, Sweden, Netherlands, Hungary
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Eli Lilly and Company; Kanisa PharmaceuticalsCompletedMyelodysplastic Syndromes | LeukemiaUnited States, Israel
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationRecruitingAcute Myeloid LeukemiaUnited States
-
Prof. Dr. Wolfgang HiddemannKompetenznetz LeukämienCompleted
-
Sunesis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Spain, Belgium, United Kingdom, Germany, Australia, Hong Kong, Denmark, France, Japan, Canada, Italy, Austria, Sweden, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcomaUnited States, Canada, Australia, Puerto Rico
-
Xuejie JiangRecruitingLeukemia, MyeloidChina
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
Incyte CorporationTerminated
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelomonocytic Leukemia-2United States
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); ImmunoGen, Inc.WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent...
-
St. Jude Children's Research HospitalAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Steven E. CoutreNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid LeukemiaUnited States
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationItaly
-
Sellas Life Sciences GroupActive, not recruitingAcute Myeloid LeukemiaUnited States, Spain, France, Taiwan, India, Hungary, Poland, Germany, Serbia, Greece
-
St. Jude Children's Research HospitalJazz PharmaceuticalsRecruitingMyeloid NeoplasmUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia... and other conditionsUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedAcute Myelogenous LeukemiaUnited States
-
The First Affiliated Hospital of Xiamen UniversityFujian Cancer Hospital; Huizhou Municipal Central Hospital; Chipscreen Biosciences... and other collaboratorsRecruitingLeukemia, Myeloid, Acute | AML Stage, AdultChina
-
University of NebraskaMillennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Non-hodgkin's LymphomaUnited States
-
Uwe PlatzbeckerGilead SciencesWithdrawnAcute Myeloid Leukemia | Myelodysplastic Neoplasm
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
M.D. Anderson Cancer CenterSchering-Plough; Enzon Pharmaceuticals, Inc.TerminatedNeoplastic MeningitisUnited States
-
New York Medical CollegeUnknownAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Chronic Myelogenous Leukemia | Burkitts Leukemia/LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); SmithKline BeechamCompleted
-
CelgeneCompletedLeukemia, Myeloid, AcuteGermany, Netherlands, Denmark
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Sumithira VasuKiadis PharmaRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blasts 10 Percent or More of Bone Marrow Nucleated Cells | Allogeneic Stem Cell Transplant RecipientUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic... and other conditionsUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaItaly, Croatia, Estonia, Czechia, France, Spain, Sweden, Bulgaria, Lithuania, Serbia, Hungary, Finland, Norway, Romania, Slovakia
-
Aileron Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand, Puerto Rico
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Institut Paoli-CalmettesCompleted
-
Dutch Childhood Oncology GroupSt. Jude Children's Research Hospital; International BFM Study GroupCompletedAcute Myeloid LeukemiaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis PharmaceuticalsActive, not recruitingLeukemiaUnited States, Canada